First-Ever Stem Cell GMP Warning Letter Cites IntelliCell
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA finds the company failed to establish procedures for a range of GMP basics, which is a problem because according to the agency the IntelliCell adipose tissue-derived stem cells are both a drug and a biologic product.